A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m⁶A reader YTHDC1.

ABSTRACT: SLC12A5, a neuron-specific potassium-chloride co-transporter, has been reported to promote tumor progression, however, the underlying mechanism remains unclear. Here we report that SLC12A5 functions as an oncogene to promote tumor progression and castration resistance of prostate cancer through the N6-methyladenosine (m⁶A) reader YTHDC1 and the transcription factor HOXB13. We have shown that the level of SLC12A5 was increased in prostate cancer, in comparison to its normal counterparts, and further elevated in castration-resistant prostate cancer (CRPC). The enhanced expression of SLC12A5 mRNA was associated with neuroendocrine prostate cancer (NEPC) progression and poor survival in prostate cancer. Furthermore, we demonstrated that SLC12A5 promoted the castration resistance dev

SUBMITTER: Yuan S 

PROVIDER: S-EPMC9822915 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature